MSB 0.51% 97.0¢ mesoblast limited

Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-388

  1. 6,317 Posts.
    lightbulb Created with Sketch. 375
    I'm not a resident in the USA....but surely with this appalling FDA decision......one that no-one can attach any sense or fairness to in the absence of ANY other viable therapy for vulnerable young kids.......it is now time to evoke the momentum swing of social media against the FDA regarding this situation. Mobilise everything to 'put it out there' to announce to the world what has just happened. With regards to extremely sick children with GVHD....surely the FDA are 'fiddling while Rome burns !!!!!' Put simply.......delays cost lives. Parents, doctors & families should now 'unleash the social media beast !!' .........without delay !!!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
-0.005(0.51%)
Mkt cap ! $1.107B
Open High Low Value Volume
98.5¢ 98.5¢ 96.0¢ $2.168M 2.226M

Buyers (Bids)

No. Vol. Price($)
1 16000 96.5¢
 

Sellers (Offers)

Price($) Vol. No.
97.0¢ 86854 7
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.